Related references
Note: Only part of the references are listed.Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways
Zuoxing Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo
Fangsheng Fu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Carnosic acid inhibits inflammation response and joint destruction on osteoclasts, fibroblast-like synoviocytes, and collagen-induced arthritis rats
Mei Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review
Zhaoyi Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis
Hui Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro
Yanwen Cheng et al.
XENOBIOTICA (2017)
Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines
Lingbo Kong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Phillygenin attenuates inflammatory responses and influences glucose metabolic parameters by inhibiting Akt activity
Wenjuan Liu et al.
RSC ADVANCES (2017)
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer
Jin Liu et al.
SCIENTIFIC REPORTS (2017)
Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis
Toral D. Zaveri et al.
BIOMATERIALS (2017)
Protective effects of phillyrin against influenza A virus in vivo
Xin-yan Qu et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Selective Regulation of MAPK Signaling Mediates RANKL-dependent Osteoclast Differentiation
Kyunghee Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Transcriptional Modulator Ifrd1 Regulates Osteoclast Differentiation through Enhancing the NF-κB/NFATc1 Pathway
Takashi Iezaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
MAGED1 Is a Negative Regulator of Bone Remodeling in Mice
Mei Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Protective Effects of Phillyrin on H2O2-induced Oxidative Stress and Apoptosis in PC12 Cells
Teng Wei et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Forsythin inhibits lipopolysaccharide-induced inflammation by suppressing JAK-STAT and p38 MAPK signalings and ROS production
Xiaolong Pan et al.
INFLAMMATION RESEARCH (2014)
Phillyrin, a Natural Lignan, Attenuates Tumor Necrosis Factor α-Mediated Insulin Resistance and Lipolytic Acceleration in 3T3-L1 Adipocytes
Poren Kong et al.
PLANTA MEDICA (2014)
Chemical Constituents from the Fruits of Forsythia suspensa and Their Antimicrobial Activity
Ping-Chung Kuo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice
Wei-ting Zhong et al.
FITOTERAPIA (2013)
Inhibition of the classical NF-kappa B pathway prevents osteoclast bone-resorbing activity
Niroshani S. Soysa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Role of the NF-kappa B axis in immune modulation of osteoclasts and bone loss
Yousef Abu-Amer et al.
AUTOIMMUNITY (2008)
The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation
Eun-Ju Chang et al.
JOURNAL OF CELL SCIENCE (2008)
Antioxidant and antibacterial activity of two compounds (forsythiaside and forsythin) isolated from Forsythia suspensa
Huanhuan Qu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1
Teruhito Yamashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-α, lipopolysaccharide, or peptidoglycan
Hitoshi Hotokezaka et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
Bone remodeling in post-menopausal osteoporosis
U. H. Lerner
JOURNAL OF DENTAL RESEARCH (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Elevated serum levels of stromal-derived factor-1α are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients
ACW Zannettino et al.
CANCER RESEARCH (2005)
Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha
N Wada et al.
BONE (2004)
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
F Ikeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanisms of disease: Osteopetrosis
J Tolar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Etiology of Paget's disease and osteoclast abnormalities
SV Reddy
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via toll-like receptor 9
W Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival
A Gingery et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Signal transduction pathways regulating osteoclast differentiation and function
S Tanaka et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2003)
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
JP David et al.
JOURNAL OF CELL SCIENCE (2002)
Dual modulation of osteoclast differentiation by lipopolysaccharide
W Zou et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
The role of osteoclast differentiation in aseptic loosening
EM Greenfield et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2002)
Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation
YM Bi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Tumor necrosis factor α-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6
K Kaji et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors
T Kikuchi et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
